EdgarLookup

Syndax Pharmaceuticals Inc

SNDX NASDAQ CIK: 0001395937 Pharmaceutical Preparations Inc. in DE
View on SEC.gov →
Overview All Filings Financials Insiders

Recent Filings

All 629 filings →
Form Description Date
SCHEDULE 13G/A Mar 27, 2026
10-K 10-K Feb 26, 2026
8-K 8-K Feb 26, 2026
S-8 S-8 Feb 26, 2026
4 4 Feb 10, 2026
4 4 Feb 10, 2026
144 Feb 9, 2026
144 Feb 9, 2026
4 4 Feb 6, 2026
4 4 Feb 6, 2026

Insider Transactions

View all →
Insider Title Type Shares Date
Goldan Keith A. Chief Financial Officer Sale 1,296 @ $9.29 Jul 16, 2025
Metzger Michael A Chief Executive Officer Sale 7,534 @ $9.29 Jul 16, 2025
Goldan Keith A. Chief Financial Officer Purchase 3,000 May 19, 2025
Huber Martin H. Jr. Purchase 5,000 @ $8.99 May 19, 2025
Katkin Keith Purchase 10,000 @ $9.11 May 19, 2025
Botwood Nicholas A.J. Head of R&D, CMO Purchase 11,765 @ $9.00 May 16, 2025
Goldan Keith A. Chief Financial Officer Sale 3,777 @ $15.50 Feb 10, 2025
Metzger Michael A Chief Executive Officer Sale 13,288 @ $15.50 Feb 10, 2025
Gallagher Neil President, Head of R&D Sale 4,618 @ $15.50 Feb 10, 2025
Gallagher Neil President, Head of R&D Award / Grant 18,500 Feb 5, 2025